JERUSALEM, Nov. 08, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptides and small therapeutic proteins, today [...] Read more »
Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences
WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical–stage global biopharmaceutical company committed to being a [...] Read more »
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
- REC–3964 is Recursion’s first new chemical entity developed using the RecursionOS.
- REC–3964 represents a novel, non–antibiotic approach with a unique mechanism of action that binds and blocks [...] Read more »
Fortrea veröffentlicht ersten Bericht zur sozialen Verantwortung des Unternehmens
DURHAM, N.C., Oct. 18, 2024 (GLOBE NEWSWIRE) — Read more »
Fortrea Publica Primeiro Relatório de Responsabilidade Social Corporativa
DURHAM, N.C., Oct. 17, 2024 (GLOBE NEWSWIRE) — A Read more »
Fortrea publie son premier rapport de Responsabilité Sociale d’Entreprise
DURHAM, Caroline du Nord, 18 oct. 2024 (GLOBE NEWSWIRE) — Read more »
Fortrea Releases Inaugural Corporate Social Responsibility Report
DURHAM, N.C., Oct. 17, 2024 (GLOBE NEWSWIRE) — Read more »
Curia verpflichtet sich zum Netto-Null-Standard von SBTi
Albany, New York, Oct. 11, 2024 (GLOBE NEWSWIRE) — Curia, ein führendes Auftragsforschungs–, Entwicklungs– und Produktionsunternehmen, gab heute seine Verpflichtung bekannt, die [...] Read more »
Curia s’engage envers la norme de neutralité carbone « net zéro » de la SBTi
Albany, New York, 11 oct. 2024 (GLOBE NEWSWIRE) — Curia, une organisation de recherche, de développement et de fabrication sous contrat de première importance fait part ce [...] Read more »
Curia Se Compromete Ao Padrão SBTi Net-Zero
Albany, NY, Oct. 11, 2024 (GLOBE NEWSWIRE) — A Curia, uma organização líder em contratos de pesquisa, desenvolvimento e fabricação, anunciou hoje seu compromisso de estabelecer [...] Read more »
Curia stellt auf der CPHI WW in Mailand eine neue Marke vor
ALBANY, New York, Oct. 08, 2024 (GLOBE NEWSWIRE) — Curia, ein führendes Unternehmen für Auftragsforschung, –entwicklung und –herstellung, hat heute seine neue Marke vorgestellt. Das Update führt eine [...] Read more »
Curia Revela Marca Atualizada na CPHI WW em Milão
ALBANY, N.Y., Oct. 08, 2024 (GLOBE NEWSWIRE) — A Curia, uma organização líder em contratos de pesquisa, desenvolvimento e fabricação, divulgou sua marca atualizada. A atualização [...] Read more »
Curia dévoile une marque plus moderne à l'occasion du salon de la CPHI Worldwide qui se tient à Milan
ALBANY, New York, 08 oct. 2024 (GLOBE NEWSWIRE) — Curia, l’un des principaux organismes de recherche, de développement et de fabrication sous contrat, a dévoilé aujourd’hui une identité de [...] Read more »
Curia Commits to SBTi Net-Zero Standard
ALBANY, N.Y., Oct. 08, 2024 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced its commitment to set near– and long–term [...] Read more »
Curia Unveils Brand Refresh at CPHI WW in Milan
ALBANY, N.Y., Oct. 07, 2024 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today unveiled its refreshed brand. The update introduces refined corporate messaging and a [...] Read more »